66 research outputs found
Hydrothermal Preparation of Gd+3 -Doped Titanate Nanotubes: Magnetic Properties and Photovoltaic Performance
Pure and Gd+3 -doped titanate nanotubes (TNTs) materials were synthesized by a hydrothermal method. Their morphology, optical properties, thermal stability, and magnetic properties were characterized by X-ray diffraction (XRD), transmission electron microscope (TEM), UV-Vis spectroscopy, thermal analysis, and magnetic measurements. It was found that doping renders Gd+3-TNT visible light active and results in smaller crystallite size and larger surface area as well as higher thermal stability compared to pure titanate nanotubes. The estimated magnetic moments point to presence of weak antiferromagnetic interaction. Application of the prepared Gd+3-TNT for modifying conventional photoanodes in polymer solar cells was attempted. Preliminary results show slightly improved photovoltaic energy conversion efficiency in the devices containing the newly designed Gd+3 -doped nanotubes
Propylbenzilylcholine Mustard Has Greater Specificity for Muscarinic m2 Receptors than for m3 Receptors Present in Cerebeflar Granule Cell Culture from Rat1
ABSTRAC
Nosocomial bloodstream infection surveillance in trauma centers: The lack of uniform standards [2]
Predictors of nosocomial bloodstream infections among critically ill adult trauma patients
Effects of AGM-1470 and pentosan polysulphate on tumorigenicity and metastasis of FGF-transfected MCF-7 cells
Previously, we described FGF-1- or FGF-4-transfected MCF-7 breast carcinoma cells which are tumorigenic and metastatic in untreated or tamoxifen-treated ovariectomised nude mice. In this study, we have assessed the effects of AGM-1470, an antiangiogenic agent, and pentosan polysulphate (PPS), an agent that abrogates the effects of FGFs, on tumour growth and metastasis produced by these FGF-transfected MCF-7 cells. Untreated or tamoxifen-treated ovariectomised mice were injected with FGF-transfected cells, treated with AGM-1470 or PPS, and tumour growth and metastasis analysed. The sensitivity of FGF-transfected and parental MCF-7 cells to AGM-1470 or PPS was also determined in vitro. Both AGM-1470 and PPS inhibited tumour growth in otherwise untreated or tamoxifen-treated mice injected with either FGF- or FGF-4-transfected MCF-7 cells. This effect was more reliably seen in tamoxifen-treated animals. AGM-1470 was about 10(5) times less potent in inhibiting the anchorage-dependent growth of parental MCF-7 or FGF-transfected MCF-7 cells than in inhibiting the growth of human umbilical vein endothelial cells. PPS did not affect the in vitro growth of the transfectants or parental cells. Thus, the growth-inhibitory effect on tumours was in excess of the effect of either drug on the same cells in tissue culture, implying that stromal elements are important determinants of the effects of these drugs. There was a positive correlation between tumour size and the extent of proximal lymph node metastasis. However, neither drug had a significant effect on the extent of metastasis to proximal or distal lymph nodes or lungs. AGM-1470 or PPS may be helpful in cases of breast carcinoma in which angiogenesis is due to expression of FGFs by the tumour cells and may be more effective when combined with tamoxifen
Expression and function of angiopoietin-1 in breast cancer
Angiopoietin-1 (Ang1) has been shown to act as an angiogenic promoter in embryonic angiogenesis by promoting vascular branching, pericyte recruitment and endothelial survival. We have investigated the role of Ang1 in tumour neovascularization under clinical conditions and in animal models. The expression of Ang1 in clinical breast cancer specimens was analysed by using laser-capture microdissection and reverse transcriptase-linked polymerase chain reaction (RT-PCR) on RNA isolated from the samples. Despite the expression of Ang1 in many human breast cancer cell lines, the gene was expressed in only three of 21 breast cancer clinical specimens, even though its receptor, Tie2, is abundant in the vasculature of all of these tumours. Ang1 was then overexpressed in a human breast cancer cell line (MCF-7) on its own and in conjunction with FGF1, an angiogenic factor shown to be able to increase the tumorigenicity of MCF-7 cells. High concentrations of Ang1 were produced in the conditioned media of the transfected cells (range 156–820 ng ml
–1
). However, in contrast to its physiological role as promoter of angiogenesis, overexpression of Ang1 did not enhance tumour growth, but instead caused up to a 3-fold retardation of tumour growth (
P
= 0.003). © 2000 Cancer Research Campaig
A Review of the Effectiveness of Guided Notes for Students who Struggle Learning Academic Content
- …